Rui Moreira (@ruimoreira_ul) 's Twitter Profile
Rui Moreira

@ruimoreira_ul

Research Institute for Medicines iMed.ULisboa

ID: 1195237374

linkhttp://imed.ulisboa.pt/research/program-areas/drug-design/medicinal-chemistry/ calendar_today18-02-2013 23:28:55

1,1K Tweet

1,1K Takipçi

1,1K Takip Edilen

Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

Tim Jonckers is presenting the Discovery of JNJ-1802, a First-in-Class, Pan-Serotype Dengue Antiviral Small Molecule #EFMCISMC24 ⁦EFMC

Tim Jonckers is presenting the Discovery of JNJ-1802, a First-in-Class, Pan-Serotype Dengue Antiviral Small Molecule #EFMCISMC24 ⁦<a href="/EuroMedChem/">EFMC</a>⁩
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

Pilar Manzano-Chinchon ⁦GSK⁩ is presenting the Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma Cruzi Proteasome Inhibitors #EFMCISMC24 ⁦EFMC

Pilar  Manzano-Chinchon ⁦<a href="/GSK/">GSK</a>⁩ is presenting the Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma Cruzi Proteasome Inhibitors #EFMCISMC24 ⁦<a href="/EuroMedChem/">EFMC</a>⁩
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

The venue for #EFMCISMC24 ⁦EFMC⁩ is an impressive building that facilitates networking and discussion with the +600 poster presenters.

The venue for #EFMCISMC24 ⁦<a href="/EuroMedChem/">EFMC</a>⁩ is an impressive building that facilitates networking and discussion with the +600 poster presenters.
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

Jorge FERNANDEZ from ⁦GSK⁩ is starting the second of First Disclosure Sessions of #EFMCISMC24, disclosing the Discovery of Clinical Candidate GSK484 as a Novel "Irresistible" Chemical Class for the Treatment of Malaria ⁦EFMC

Jorge FERNANDEZ from ⁦<a href="/GSK/">GSK</a>⁩ is starting the second of First Disclosure Sessions of #EFMCISMC24, disclosing the Discovery of Clinical Candidate GSK484 as a Novel "Irresistible" Chemical Class for the Treatment of Malaria ⁦<a href="/EuroMedChem/">EFMC</a>⁩
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

First time disclosure of NVP-DFF332 as a Selective Inhibitor of the Transcription Factor Hypoxia-Inducible Factor-2ALPHA (HIF-2α) Robin FAIRHURST ⁦Novartis⁩ #EFMCISMC24 ⁦EFMC

First time disclosure of NVP-DFF332 as a Selective Inhibitor of the Transcription Factor Hypoxia-Inducible Factor-2ALPHA (HIF-2α) Robin FAIRHURST ⁦<a href="/Novartis/">Novartis</a>⁩ #EFMCISMC24 ⁦<a href="/EuroMedChem/">EFMC</a>⁩
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

⁦Craig Crews starts the IUPAC-Richter Prize in Medicinal Chemistry 2024 Lecture on Induced Proximity: Exploring New Therapeutic Modalities #EFMCISMC24 ⁦EFMC

⁦Craig Crews starts the IUPAC-Richter Prize in Medicinal Chemistry 2024 Lecture on Induced Proximity: Exploring New Therapeutic Modalities #EFMCISMC24 ⁦<a href="/EuroMedChem/">EFMC</a>⁩
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

Rebecca Buller, the winner of the ⁦EFMC⁩ PRIZE FOR A YOUNG MEDICINAL CHEMIST OR CHEMICAL BIOLOGIST IN ACADEMIA, is presenting her research on Engineering Aliphatic Halogenases #EFMCISMC24

Rebecca Buller, the winner of the ⁦<a href="/EuroMedChem/">EFMC</a>⁩ PRIZE FOR A YOUNG MEDICINAL CHEMIST OR CHEMICAL BIOLOGIST IN ACADEMIA, is presenting her research on Engineering Aliphatic Halogenases #EFMCISMC24
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

Samuele Cazzamalli, winner of the ⁦EFMC⁩ PRIZE FOR A YOUNG MEDICINAL CHEMIST OR CHEMICAL BIOLOGIST IN INDUSTRY, presenting DNA-Encoded Chemical Libraries for the Discovery of Highly Potent Tumor-Targeting Ligands #EFMCISMC24

Samuele Cazzamalli, winner of the ⁦<a href="/EuroMedChem/">EFMC</a>⁩ PRIZE FOR A YOUNG MEDICINAL CHEMIST OR CHEMICAL BIOLOGIST IN INDUSTRY, presenting DNA-Encoded Chemical Libraries for the Discovery of Highly Potent Tumor-Targeting Ligands #EFMCISMC24
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

To start the #EFMCISMC24 Early Career Women in ChemMed and ChemBio session, ⁦Maria-Laura Bolognesi⁩ will talk about Medicinal Chemistry and the United Development Goals: a Personal Adventure ⁦EFMC

To start the #EFMCISMC24 Early Career Women in ChemMed and ChemBio session, ⁦<a href="/mlbolognesi/">Maria-Laura Bolognesi</a>⁩ will talk about Medicinal Chemistry and the United Development Goals: a Personal Adventure ⁦<a href="/EuroMedChem/">EFMC</a>⁩
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

Zaneta NIKOLOVSKA-COLESKA starts the ⁦International Chemical Biology Society⁩ session at #EFMCISMC24, with lecture Targeting the Longevity Regulator PAPP-A with Small Molecule Inhibitors ⁦EFMC

Zaneta NIKOLOVSKA-COLESKA starts the ⁦<a href="/ChemBioSociety/">International Chemical Biology Society</a>⁩ session at #EFMCISMC24, with lecture Targeting the Longevity Regulator PAPP-A with Small Molecule Inhibitors ⁦<a href="/EuroMedChem/">EFMC</a>⁩
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

The Late Breaking News session at #EFMCISMC24 starts with a presentation on Isocyanide as a Game-Changer in Medicinal Chemistry, by Francesca BRUNELL ⁦EFMC

The Late Breaking News session at #EFMCISMC24 starts with a presentation on Isocyanide as a Game-Changer in Medicinal Chemistry, by Francesca BRUNELL ⁦<a href="/EuroMedChem/">EFMC</a>⁩
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

The last talk of the Last Breaking News at #EFMCISMC24, on the Discovery of Highly Selective SYK Inhibitors to Treat Severe Asthma by Matthias HOFFMANN ⁦Boehringer Ingelheim⁩ ⁦EFMC

The last talk of the Last Breaking News at #EFMCISMC24, on the Discovery of Highly Selective SYK Inhibitors to Treat Severe Asthma by Matthias HOFFMANN ⁦<a href="/Boehringer/">Boehringer Ingelheim</a>⁩ ⁦<a href="/EuroMedChem/">EFMC</a>⁩
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

Luc Van Hijfte⁩ starts the closing ceremony of #EFMCISMC24, highlighting the success of the event, the quality of the scientific content and the opportunities for networking!

⁦<a href="/Luc_Van_Hijfte/">Luc Van Hijfte</a>⁩ starts the closing ceremony of #EFMCISMC24, highlighting the success of the event, the quality of the scientific content and the opportunities for networking!
Gianluca Sbardella (@g_sbardella) 's Twitter Profile Photo

Time of concluding remarks at #EFMCISMC24. The EFMC President Luc Van Hijfte announces the winners of the poster prizes and says what everyone knows: this edition will be never forgotten! EFMC DCF-SCI

Time of concluding remarks at #EFMCISMC24. The <a href="/EuroMedChem/">EFMC</a> President <a href="/Luc_Van_Hijfte/">Luc Van Hijfte</a> announces the winners of the poster prizes and says what everyone knows: this edition will be never forgotten!
<a href="/EuroMedChem/">EFMC</a> 
<a href="/DCFSCI/">DCF-SCI</a>
Gianluca Sbardella (@g_sbardella) 's Twitter Profile Photo

And finally is Roberto Di Santo’s turn to thank all the members of the IOC of #EFMCISMC24, the LOC, and all the people that made possible to obtain such a success, in particular Ly Differding and the LDO team. EFMC

And finally is <a href="/RobertoDiSanto7/">Roberto Di Santo</a>’s turn to thank all the members of the IOC of #EFMCISMC24, the LOC, and all the people that made possible to obtain such a success, in particular <a href="/Lydiff/">Ly Differding</a> and the LDO team.
<a href="/EuroMedChem/">EFMC</a>
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

The #EFMCYMCS24 has started with an inspiring lecture by Kelly Chibale ⁦UCT⁩ ⁦H3D⁩ on Cell-Based Medicinal Chemistry Optimization of Phenotypic Hits in Malaria Drug Discovery ⁦EFMC

The #EFMCYMCS24 has started with an inspiring lecture by Kelly Chibale ⁦<a href="/UCT_news/">UCT</a>⁩ ⁦<a href="/H3D_UCT/">H3D</a>⁩ on Cell-Based Medicinal Chemistry Optimization of Phenotypic Hits in Malaria Drug Discovery ⁦<a href="/EuroMedChem/">EFMC</a>⁩
Rui Moreira (@ruimoreira_ul) 's Twitter Profile Photo

Maria J Silva, the Winner of the young medicinal chemist meeting in Portugal, presents her PhD work Multimodal Protein Conjugates by Site-Selective Cysteine Dual Modification at the #EFMCYMCS24 ⁦⁩ The project was supervised by ⁦Pedro M. P. Gois⁩ and ⁦Gasser Group

Maria J Silva, the Winner of the young medicinal chemist meeting in Portugal, presents her PhD work Multimodal Protein Conjugates by Site-Selective Cysteine Dual Modification at the #EFMCYMCS24 ⁦⁩ The project was supervised by ⁦<a href="/GoisLab/">Pedro M. P. Gois</a>⁩ and ⁦<a href="/GasserGroup/">Gasser Group</a>⁩